Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
"Skin microbiome restoration" is not a specific molecule or receptor but rather refers to the process or therapeutic strategy aimed at rebalancing and supporting the healthy community of microorganisms—bacteria, fungi, viruses—that reside on human skin[3][5][7]. The skin microbiome plays a critical role in maintaining barrier integrity, modulating immune responses, protecting against pathogenic organisms, regulating inflammation, and supporting wound healing[3][4][5]. Disruption of this microbial balance (dysbiosis) is associated with various dermatological conditions such as acne, eczema/atopic dermatitis, psoriasis, infections, and impaired wound repair[2][3][4]. Restoration strategies may include topical antimicrobials combined with steroids to reduce harmful bacteria like Staphylococcus while promoting beneficial ones like Cutibacterium; use of probiotics; prebiotic skincare formulations; dietary interventions; and lifestyle modifications that support both gut and skin health[1][2][6]. These approaches are designed to restore the natural diversity and function of the cutaneous microbial ecosystem rather than target a single molecular entity. Because "skin microbiome restoration" describes an approach or therapeutic goal—not a discrete protein target such as a receptor or enzyme—it does not have canonical abbreviations nor does it fit into standard molecular classification schemes. There are no direct interacting drugs in the conventional sense; instead there are classes of interventions (e.g., topical antimicrobials/probiotics) that influence overall microbial composition rather than binding to a specific molecular target. Similarly, mechanisms of action relate broadly to ecological modulation rather than ligand-receptor interactions. Therefore: **This entry is not considered a valid therapeutic target molecule/receptor.** It should be flagged as incorrect if used in databases requiring discrete molecular targets for drug discovery purposes. However, it remains highly relevant as an emerging area in dermatology focused on holistic management through ecological restoration[1][9]. If you need information about specific molecules within the context of "skin microbiome restoration," such as *Staphylococcus epidermidis* metabolites or host receptors involved in microbe-host signaling (e.g., aryl hydrocarbon receptor), please specify further.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Skin microbiome.